Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 136 articles:
HTML format



Single Articles


    July 2021
  1. WANG H, Zhu Y, Chen H, Yang N, et al
    Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop.
    Cancer Lett. 2021;518:140-151.
    PubMed     Abstract available


  2. STADLER M, Pudelko K, Biermeier A, Walterskirchen N, et al
    Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.
    Cancer Lett. 2021;520:184-200.
    PubMed     Abstract available


  3. JING Z, He X, Jia Z, Sa Y, et al
    NCAPD2 inhibits autophagy by regulating Ca(2+)/CAMKK2/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis to promote colorectal cancer.
    Cancer Lett. 2021;520:26-37.
    PubMed     Abstract available


    June 2021
  4. ZHANG H, Chi J, Hu J, Ji T, et al
    Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Cancer Lett. 2021 Jun 30. pii: S0304-3835(21)00310.
    PubMed     Abstract available


  5. GE C, Wang Y, Feng Y, Wang S, et al
    Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone.
    Cancer Lett. 2021 Jun 21. pii: S0304-3835(21)00300.
    PubMed     Abstract available


  6. LI W, Ma Y, He L, Li H, et al
    Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR-targeted therapy response in colorectal cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00271.
    PubMed     Abstract available


  7. SUI Q, Peng J, Han K, Lin J, et al
    Corrigendum to "Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer" [Canc. Lett. 500 (2021) 119-131].
    Cancer Lett. 2021;516:57-60.
    PubMed    


    May 2021
  8. LI J, Tian L, Jing Z, Guo Z, et al
    Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
    Cancer Lett. 2021;516:13-27.
    PubMed     Abstract available


  9. CHEN J, Wang H, Jia L, He J, et al
    Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer.
    Cancer Lett. 2021 May 14. pii: S0304-3835(21)00223.
    PubMed     Abstract available


    March 2021
  10. NICOLAZZO C, Barault L, Caponnetto S, De Renzi G, et al
    True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature.
    Cancer Lett. 2021;507:89-96.
    PubMed     Abstract available


    February 2021
  11. YANG Y, Yan X, Li X, Ma Y, et al
    Invited review article: Cancer letters long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.
    Cancer Lett. 2021 Feb 9. pii: S0304-3835(21)00025.
    PubMed     Abstract available


    January 2021
  12. SI W, Zhou B, Xie W, Li H, et al
    Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.
    Cancer Lett. 2021;497:28-40.
    PubMed     Abstract available


  13. OH Y, Jung HR, Min S, Kang J, et al
    Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers.
    Cancer Lett. 2021;497:123-136.
    PubMed     Abstract available


  14. WAN J, Wu Y, Huang L, Tian Y, et al
    ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8(+) T cells.
    Cancer Lett. 2021 Jan 8. pii: S0304-3835(21)00011.
    PubMed     Abstract available


  15. BAI D, Wu Y, Deol P, Nobumori Y, et al
    Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation.
    Cancer Lett. 2021;496:127-133.
    PubMed     Abstract available


    December 2020
  16. HUANG X, Zhu X, Yu Y, Zhu W, et al
    Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Cancer Lett. 2020 Dec 29. pii: S0304-3835(20)30685.
    PubMed     Abstract available


  17. LIN R, Han C, Ding Z, Shi H, et al
    Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection.
    Cancer Lett. 2020;495:165-179.
    PubMed     Abstract available


  18. SUI Q, Peng J, Han K, Lin J, et al
    Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
    Cancer Lett. 2020 Dec 15. pii: S0304-3835(20)30667.
    PubMed     Abstract available


  19. PENG W, Zhang C, Peng J, Huang Y, et al
    Lnc-FAM84B-4 acts as an oncogenic lncRNA by interacting with protein hnRNPK to restrain MAPK phosphatases-DUSP1 expression.
    Cancer Lett. 2020;494:94-106.
    PubMed     Abstract available


    November 2020
  20. JAO TM, Fang WH, Ciou SC, Yu SL, et al
    PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer.
    Cancer Lett. 2020 Nov 30. pii: S0304-3835(20)30610.
    PubMed     Abstract available


  21. HONG EH, Cho J, Ahn JH, Kwon BE, et al
    Plasmacytoid dendritic cells regulate colitis-associated tumorigenesis by controlling myeloid-derived suppressor cell infiltration.
    Cancer Lett. 2020;493:102-112.
    PubMed     Abstract available


  22. TAO H, Cheng L, Liu L, Wang H, et al
    A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity.
    Cancer Lett. 2020;493:91-101.
    PubMed     Abstract available


  23. XIAO Q, Lu W, Kong X, Shao YW, et al
    Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
    Cancer Lett. 2020 Nov 26. pii: S0304-3835(20)30627.
    PubMed     Abstract available


  24. DUROSS AN, Landry MR, Thomas CR, Neufeld MJ, et al
    Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer.
    Cancer Lett. 2020 Nov 21. pii: S0304-3835(20)30618.
    PubMed     Abstract available


  25. HASES L, Indukuri R, Birgersson M, Nguyen-Vu T, et al
    Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes.
    Cancer Lett. 2020;492:54-62.
    PubMed     Abstract available


    October 2020
  26. FENG M, Zhao Z, Yang M, Ji J, et al
    T-cell-based immunotherapy in colorectal cancer.
    Cancer Lett. 2020 Oct 29. pii: S0304-3835(20)30574.
    PubMed     Abstract available


  27. LI N, Tang J, Yang J, Zhu B, et al
    Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice.
    Cancer Lett. 2020 Oct 28. pii: S0304-3835(20)30579.
    PubMed     Abstract available


  28. YU Z, Du J, Zhao Y, Gao Y, et al
    A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3beta signaling.
    Cancer Lett. 2020 Oct 28. pii: S0304-3835(20)30499.
    PubMed     Abstract available


  29. YORITA N, Yuge R, Takigawa H, Atsushi O, et al
    Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model.
    Cancer Lett. 2020 Oct 28. pii: S0304-3835(20)30575.
    PubMed     Abstract available


  30. QIAO S, Lv C, Tao Y, Miao Y, et al
    Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer.
    Cancer Lett. 2020;491:162-179.
    PubMed     Abstract available


  31. ROBRAHN L, Jiao L, Cramer T
    Barrier integrity and chronic inflammation mediated by HIF-1 impact on intestinal tumorigenesis.
    Cancer Lett. 2020;490:186-192.
    PubMed     Abstract available


  32. ZHENG X, Liu J, Li X, Tian R, et al
    Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells.
    Cancer Lett. 2020 Oct 8. pii: S0304-3835(20)30507.
    PubMed     Abstract available


  33. SASAKI M, Miyoshi N, Fujino S, Saso K, et al
    The meiosis-specific cohesin component stromal antigen 3 promotes cell migration and chemotherapeutic resistance in colorectal cancer.
    Cancer Lett. 2020 Oct 8. pii: S0304-3835(20)30504.
    PubMed     Abstract available


    September 2020
  34. ZHAO H, Yan C, Hu Y, Mu L, et al
    Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
    Cancer Lett. 2020 Sep 5. pii: S0304-3835(20)30458.
    PubMed     Abstract available


  35. WU Q, Liu W, Wang J, Zhu L, et al
    Exosomal noncoding RNAs in colorectal cancer.
    Cancer Lett. 2020 Sep 5. pii: S0304-3835(20)30451.
    PubMed     Abstract available


  36. ROTHKAMM K, Christiansen S, Rieckmann T, Horn M, et al
    Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays.
    Cancer Lett. 2020;493:179-188.
    PubMed     Abstract available


    July 2020
  37. QI S, Perrino S, Miao X, Lamarche-Vane N, et al
    The chemokine CCL7 regulates invadopodia maturation and MMP-9 mediated collagen degradation in liver-metastatic carcinoma cells.
    Cancer Lett. 2020;483:98-113.
    PubMed     Abstract available


  38. ZHANG Y, Wang S, Lai Q, Fang Y, et al
    Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGF-beta1 positive feedback loop.
    Cancer Lett. 2020 Jul 27. pii: S0304-3835(20)30380.
    PubMed     Abstract available


    June 2020
  39. WU H, Singh S, Xie Z, Li X, et al
    Landscape characterization of chimeric RNAs in colorectal cancer.
    Cancer Lett. 2020 Jun 10. pii: S0304-3835(20)30299.
    PubMed     Abstract available


    May 2020
  40. SATAPATHY SR, Sjolander A
    Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
    Cancer Lett. 2020 May 28. pii: S0304-3835(20)30285.
    PubMed     Abstract available


  41. YAN S, Wang H, Chen X, Liang C, et al
    MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C.
    Cancer Lett. 2020 May 27. pii: S0304-3835(20)30215.
    PubMed     Abstract available


  42. HOU Z, Sun L, Xu F, Hu F, et al
    Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Cancer Lett. 2020;487:63-73.
    PubMed     Abstract available


  43. KIYASU Y, Kawada K, Hirai H, Ogawa R, et al
    Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.
    Cancer Lett. 2020 May 27. pii: S0304-3835(20)30290.
    PubMed     Abstract available


    April 2020
  44. TIAN H, Kang Y, Song X, Xu Y, et al
    PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses.
    Cancer Lett. 2020;476:170-182.
    PubMed     Abstract available


  45. LU C, Klement JD, Yang D, Albers T, et al
    SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.
    Cancer Lett. 2020;476:87-96.
    PubMed     Abstract available


    March 2020
  46. WANG Y, Lu JH, Wang F, Wang YN, et al
    Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
    Cancer Lett. 2020;473:74-89.
    PubMed     Abstract available


  47. TAM BY, Chiu K, Chung H, Bossard C, et al
    The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Cancer Lett. 2020;473:186-197.
    PubMed     Abstract available


  48. ZHAO C, Qiu S, He J, Peng Y, et al
    Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.
    Cancer Lett. 2020 Mar 14. pii: S0304-3835(20)30129.
    PubMed     Abstract available


  49. LAI CH, Chen RY, Hsieh HP, Tsai SJ, et al
    A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis.
    Cancer Lett. 2020;472:97-107.
    PubMed     Abstract available


  50. LEE SY, Yang SB, Choi YM, Oh SJ, et al
    Heat-killed Mycobacterium paragordonae therapy exerts an anti-cancer immune response via enhanced immune cell mediated oncolytic activity in xenograft mice model.
    Cancer Lett. 2020;472:142-150.
    PubMed     Abstract available


    February 2020
  51. FAN M, Ma X, Wang F, Zhou Z, et al
    MicroRNA-30b-5p functions as a metastasis suppressor in colorectal cancer by targeting Rap1b.
    Cancer Lett. 2020 Feb 26. pii: S0304-3835(20)30084.
    PubMed     Abstract available


  52. QIN Y, Shembrey C, Smith J, Paquet-Fifield S, et al
    Laminin 521 enhances self-renewal via Stat3 activation and promotes tumor progression in Colorectal Cancer.
    Cancer Lett. 2020 Feb 24. pii: S0304-3835(20)30095.
    PubMed     Abstract available


  53. GAO Q, Li XX, Xu YM, Zhang JZ, et al
    IRE1alpha-targeting Downregulates ABC Transporters and Overcomes Drug Resistance of Colon Cancer Cells.
    Cancer Lett. 2020 Feb 12. pii: S0304-3835(20)30069.
    PubMed     Abstract available


  54. XIAO YW, Zhong JN, Zhong BY, Huang JY, et al
    Exosomes as potential sources of biomarkers in colorectal cancer.
    Cancer Lett. 2020 Feb 7. pii: S0304-3835(20)30047.
    PubMed     Abstract available


    January 2020
  55. KE Z, Wang C, Wu T, Wang W, et al
    PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis.
    Cancer Lett. 2020;469:437-446.
    PubMed     Abstract available


  56. WANG D, Wang X, Si M, Yang J, et al
    Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Cancer Lett. 2020 Jan 10. pii: S0304-3835(20)30013.
    PubMed     Abstract available


    December 2019
  57. LIU C, Zhao Y, Wang J, Yang Y, et al
    FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
    Cancer Lett. 2019 Dec 4. pii: S0304-3835(19)30608.
    PubMed     Abstract available


    October 2019
  58. EILERTSEN IA, Moosavi SH, Stromme JM, Nesbakken A, et al
    Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
    Cancer Lett. 2019 Oct 30. pii: S0304-3835(19)30543.
    PubMed     Abstract available


  59. EYLEM CC, Yilmaz M, Derkus B, Nemutlu E, et al
    Untargeted Multi-Omic Analysis of Colorectal Cancer-Specific Exosomes Reveals Joint Pathways of Colorectal Cancer in both Clinical Samples and Cell Culture.
    Cancer Lett. 2019 Oct 25. pii: S0304-3835(19)30541.
    PubMed     Abstract available


  60. LIU Z, Xie Y, Xiong Y, Liu S, et al
    TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.
    Cancer Lett. 2019 Oct 17. pii: S0304-3835(19)30517.
    PubMed     Abstract available


  61. LU YX, Ju HQ, Wang F, Chen LZ, et al
    Corrigendum to "Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].
    Cancer Lett. 2019 Oct 14. pii: S0304-3835(19)30492.
    PubMed    


  62. ZHANG Y, Song J, Zhao Z, Yang M, et al
    Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Cancer Lett. 2019 Oct 11. pii: S0304-3835(19)30513.
    PubMed     Abstract available


    September 2019
  63. CHEN S, Yue T, Huang Z, Zhu J, et al
    Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells.
    Cancer Lett. 2019 Sep 19. pii: S0304-3835(19)30470.
    PubMed     Abstract available


    June 2019
  64. CHENG X, Feng H, Wu H, Jin Z, et al
    Corrigendum to "Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer" [Cancer Lett. 431 (2018) 105-114].
    Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30315.
    PubMed    


    May 2019
  65. ZHANG S, Cao L, Li Z, Qu D, et al
    Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis.
    Cancer Lett. 2019;450:123-131.
    PubMed     Abstract available


  66. KIM CW, Oh ET, Kim JM, Park JS, et al
    Corrigendum to "Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity" [Cancer Lett. 416 (2018) 31-41].
    Cancer Lett. 2019 May 4. pii: S0304-3835(19)30255.
    PubMed    


  67. LEE WK, Thevenod F
    Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers.
    Cancer Lett. 2019;449:237-251.
    PubMed     Abstract available


    April 2019
  68. WANG Q, Dai L, Wang Y, Deng J, et al
    Targeted demethylation of the SARI promotor impairs colon tumour growth.
    Cancer Lett. 2019;448:132-143.
    PubMed     Abstract available


  69. HILLERT EK, Brnjic S, Zhang X, Mazurkiewicz M, et al
    Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
    Cancer Lett. 2019;448:70-83.
    PubMed     Abstract available


  70. TIAN X, Liu K, Zu X, Ma F, et al
    3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2.
    Cancer Lett. 2019;448:20-30.
    PubMed     Abstract available


  71. HUANG Q, Chen Z, Cheng P, Huang Y, et al
    LYRM2 directly Regulates Complex I Activity to Support Tumor Growth in Colorectal Cancer by Oxidative Phosphorylation.
    Cancer Lett. 2019 Apr 17. pii: S0304-3835(19)30252.
    PubMed     Abstract available


  72. HE D, Ma Z, Fang C, Ding J, et al
    Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer.
    Cancer Lett. 2019;454:53-65.
    PubMed     Abstract available


  73. ZHANG R, Li X, Wei L, Qin Y, et al
    Lemur tyrosine kinase 2 acts as a positive regulator of NF-kappaB activation and colon cancer cell proliferation.
    Cancer Lett. 2019;454:70-77.
    PubMed     Abstract available


    March 2019
  74. GAO T, Hu Q, Hu X, Lei Q, et al
    Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
    Cancer Lett. 2019;445:11-23.
    PubMed     Abstract available


  75. YANG J, Xu WW, Hong P, Ye F, et al
    Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.
    Cancer Lett. 2019 Mar 11. pii: S0304-3835(19)30149.
    PubMed     Abstract available


  76. WANG Q, Feng Y, Peng W, Ji D, et al
    Long noncoding RNA Linc02023 regulates PTEN stability and suppresses tumorigenesis of colorectal cancer in a PTEN-dependent pathway.
    Cancer Lett. 2019 Mar 5. pii: S0304-3835(19)30127.
    PubMed     Abstract available


    February 2019
  77. ULLMANN P, Nurmik M, Schmitz M, Rodriguez F, et al
    Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity.
    Cancer Lett. 2019 Feb 18. pii: S0304-3835(19)30108.
    PubMed     Abstract available


  78. WANG H, Jiang H, Corbet C, de Mey S, et al
    Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.
    Cancer Lett. 2019 Feb 18. pii: S0304-3835(19)30112.
    PubMed     Abstract available


  79. WEI F, Zhang T, Deng SC, Wei JC, et al
    PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
    Cancer Lett. 2019 Feb 15. pii: S0304-3835(19)30100.
    PubMed     Abstract available


  80. YU L, Dong L, Wang Y, Liu L, et al
    Reversible Regulation of SATB1 Ubiquitination by USP47 and SMURF2 Mediates Colon Cancer Cell Proliferation and Tumor Progression.
    Cancer Lett. 2019 Feb 8. pii: S0304-3835(19)30068.
    PubMed     Abstract available


  81. DE VERA AA, Gupta P, Lei Z, Liao D, et al
    Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    Cancer Lett. 2019;442:91-103.
    PubMed     Abstract available


    January 2019
  82. BELHADJ S, Moutinho C, Mur P, Setien F, et al
    Germline variation in O(6)-Methylguanine-DNA Methyltransferase (MGMT) as cause of hereditary colorectal cancer.
    Cancer Lett. 2019 Jan 21. pii: S0304-3835(19)30031.
    PubMed     Abstract available


  83. JEONG S, Yun HK, Jeong YA, Jo MJ, et al
    Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells.
    Cancer Lett. 2019 Jan 17. pii: S0304-3835(19)30023.
    PubMed     Abstract available


  84. JIN F, Yang R, Wei Y, Wang D, et al
    HIF-1alpha-induced miR-23a approximately 27a approximately 24 cluster promotes colorectal cancer progression via reprogramming metabolism.
    Cancer Lett. 2019;440-441:211-222.
    PubMed     Abstract available


  85. KIM YJ, Lee JH, Jin S, Kim JH, et al
    Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.
    Cancer Lett. 2019;440-441:168-179.
    PubMed     Abstract available


  86. VIDIMAR V, Licona C, Ceron-Camacho R, Guerin E, et al
    A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53.
    Cancer Lett. 2019;440-441:145-155.
    PubMed     Abstract available


  87. JI N, Yang Y, Cai CY, Lei ZN, et al
    Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Cancer Lett. 2019;440-441:82-93.
    PubMed     Abstract available


    December 2018
  88. TAKEDA S, Shigeyasu K, Okugawa Y, Yoshida K, et al
    Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30724.
    PubMed     Abstract available


    November 2018
  89. DENG S, Deng Q, Zhang Y, Ye H, et al
    Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.
    Cancer Lett. 2018 Nov 24. pii: S0304-3835(18)30683.
    PubMed     Abstract available


  90. DING C, Tang W, Wu H, Fan X, et al
    The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.
    Cancer Lett. 2018 Nov 22. pii: S0304-3835(18)30678.
    PubMed     Abstract available


  91. TREMBLE LF, O'Brien MA, Forde PF
    Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer.
    Cancer Lett. 2018 Nov 22. pii: S0304-3835(18)30680.
    PubMed     Abstract available


    October 2018
  92. DENG Q, Geng Y, Zhao L, Li R, et al
    NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.
    Cancer Lett. 2018;442:21-30.
    PubMed     Abstract available


  93. ZHANG YK, Wang YJ, Lei ZN, Zhang GN, et al
    Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
    Cancer Lett. 2018 Oct 27. pii: S0304-3835(18)30647.
    PubMed     Abstract available


  94. ZHANG J, Ren P, Xu D, Liu X, et al
    Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
    Cancer Lett. 2018 Oct 18. pii: S0304-3835(18)30624.
    PubMed     Abstract available


  95. LUO Y, Chen JJ, Lv Q, Qin J, et al
    Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/beta-catenin signaling pathway.
    Cancer Lett. 2018 Oct 9. pii: S0304-3835(18)30606.
    PubMed     Abstract available


    September 2018
  96. WANG S, Xiao Z, Hong Z, Jiao H, et al
    FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Cancer Lett. 2018 Sep 22. pii: S0304-3835(18)30591.
    PubMed     Abstract available


    August 2018
  97. BELLAMKONDA K, Satapathy SR, Douglas D, Chandrashekar N, et al
    Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
    Cancer Lett. 2018 Aug 22. pii: S0304-3835(18)30531.
    PubMed     Abstract available


  98. TAN X, Zhang Z, Yao H, Shen L, et al
    Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway.
    Cancer Lett. 2018 Aug 14. pii: S0304-3835(18)30524.
    PubMed     Abstract available


  99. LIU Y, Yang EJ, Zhang B, Miao Z, et al
    PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A.
    Cancer Lett. 2018 Aug 14. pii: S0304-3835(18)30523.
    PubMed     Abstract available


    July 2018
  100. HEIMER S, Knoll G, Steixner C, Calance DN, et al
    Hypertonicity-imposed BCL-XL addiction primes colorectal cancer cells for death.
    Cancer Lett. 2018;435:23-31.
    PubMed     Abstract available


  101. WU F, Liu F, Dong L, Yang H, et al
    miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.
    Cancer Lett. 2018 Jul 26. pii: S0304-3835(18)30495.
    PubMed     Abstract available


  102. LIANG KH, Tso HC, Hung SH, Kuan II, et al
    Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
    Cancer Lett. 2018;433:165-175.
    PubMed     Abstract available


    June 2018
  103. HONG Y, Liew SC, Thean LF, Tang CL, et al
    Human colorectal cancer initiation is bidirectional, and cell growth, metabolic genes and transporter genes are early drivers of tumorigenesis.
    Cancer Lett. 2018;431:213-218.
    PubMed     Abstract available


    May 2018
  104. CHENG X, Feng H, Wu H, Jin Z, et al
    Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer.
    Cancer Lett. 2018;431:105-114.
    PubMed     Abstract available


  105. LI Y, Oliver PG, Lu W, Pathak V, et al
    Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
    Cancer Lett. 2018;422:131.
    PubMed    


  106. LEE YH, Song NY, Suh J, Kim DH, et al
    Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1.
    Cancer Lett. 2018 May 25. pii: S0304-3835(18)30369.
    PubMed     Abstract available


  107. LI SZ, Zeng F, Li J, Shu QP, et al
    Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.
    Cancer Lett. 2018;431:43-53.
    PubMed     Abstract available


    April 2018
  108. TREMBLE LF, O'Brien MA, Forde PF, Soden DM, et al
    ICOS activation in combination with electrochemotherapy generates effective anti-cancer immunological responses in murine models of primary, secondary and metastatic disease.
    Cancer Lett. 2018;420:109-115.
    PubMed     Abstract available


  109. JIAN Y, Wang M, Zhang Y, Ou R, et al
    Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30273.
    PubMed     Abstract available


  110. SONG J, Wang T, Xu W, Wang P, et al
    HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.
    Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30263.
    PubMed     Abstract available


  111. REN XL, Qiao YD, Li JY, Li XM, et al
    Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation.
    Cancer Lett. 2018;419:245-256.
    PubMed     Abstract available


    March 2018
  112. JIANG H, Li T, Qu Y, Wang X, et al
    Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
    Cancer Lett. 2018 Mar 28. pii: S0304-3835(18)30241.
    PubMed     Abstract available


  113. BASU S, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Cancer Lett. 2018 Mar 15. pii: S0304-3835(18)30219.
    PubMed     Abstract available


  114. TAN K, Leong SM, Kee Z, Caramat PV, et al
    Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients.
    Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30180.
    PubMed     Abstract available


    February 2018
  115. BAE WK, Hong CS, Park MR, Sun EG, et al
    TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.
    Cancer Lett. 2018;415:106-116.
    PubMed     Abstract available


  116. AL-HAIDARI A, Algaber A, Madhi R, Syk I, et al
    MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).
    Cancer Lett. 2018;421:145-151.
    PubMed     Abstract available


  117. SHUAI W, Wu J, Chen S, Liu R, et al
    SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Cancer Lett. 2018 Feb 16. pii: S0304-3835(18)30156.
    PubMed     Abstract available


  118. OU C, Sun Z, Li X, Li X, et al
    Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
    Cancer Lett. 2018 Feb 8. pii: S0304-3835(18)30106.
    PubMed    


  119. GRUNDEMANN C, Huber R
    Chemoprevention with isothiocyanates - From bench to bedside.
    Cancer Lett. 2018;414:26-33.
    PubMed     Abstract available


    January 2018
  120. PORCELLINI E, Laprovitera N, Riefolo M, Ravaioli M, et al
    Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications.
    Cancer Lett. 2018 Jan 19. pii: S0304-3835(18)30071.
    PubMed     Abstract available


  121. ZHANG S, Hu B, You Y, Yang Z, et al
    Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21(Cip1/WAF1).
    Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30067.
    PubMed     Abstract available


  122. KIM T, Croce CM
    Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.
    Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30006.
    PubMed     Abstract available


    December 2017
  123. KIM CW, Oh ET, Kim JM, Park JS, et al
    Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
    Cancer Lett. 2017;416:31-41.
    PubMed     Abstract available


  124. BYUN MR, Hwang JH, Kim AR, Kim KM, et al
    SRC activates TAZ for intestinal tumorigenesis and regeneration.
    Cancer Lett. 2017;410:32-40.
    PubMed     Abstract available


  125. FANG Z, Gong C, Yu S, Zhou W, et al
    NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Cancer Lett. 2017 Dec 1. pii: S0304-3835(17)30765.
    PubMed     Abstract available


    November 2017
  126. BLEAU AM, Redrado M, Nistal-Villan E, Villalba M, et al
    miR-146a targets c-met and abolishes colorectal cancer liver metastasis.
    Cancer Lett. 2017 Nov 10. pii: S0304-3835(17)30702.
    PubMed     Abstract available


    October 2017
  127. KIM C, Hong Y, Lee H, Kang H, et al
    MicroRNA-195 Desensitizes HCT116 Human Colon Cancer Cells to 5-Fluorouracil.
    Cancer Lett. 2017 Oct 25. pii: S0304-3835(17)30659.
    PubMed     Abstract available


  128. ZHUGE W, Chen R, Vladimir K, Dong X, et al
    Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Cancer Lett. 2017 Oct 13. pii: S0304-3835(17)30630.
    PubMed     Abstract available


  129. LIANG Z, Yang Y, He Y, Yang P, et al
    SUMOylation of IQGAP1 promotes the development of colorectal cancer.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30607.
    PubMed     Abstract available


  130. SHUKLA K, Sonowal H, Saxena A, Ramana KV, et al
    Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO1/AMPK pathway in colon cancer cells.
    Cancer Lett. 2017 Oct 3. pii: S0304-3835(17)30584.
    PubMed     Abstract available


    September 2017
  131. FANG C, Qiu S, Sun F, Li W, et al
    Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30562.
    PubMed     Abstract available


  132. YAGDI EFE E, Mazumder A, Lee JY, Gaigneaux A, et al
    Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30561.
    PubMed     Abstract available


  133. LI W, Qiu T, Guo L, Ying J, et al
    Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30564.
    PubMed     Abstract available


  134. SUN LN, Zhi Z, Chen LY, Zhou Q, et al
    SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30548.
    PubMed     Abstract available


  135. RADHAKRISHNAN H, Ilm K, Walther W, Shirasawa S, et al
    MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.
    Cancer Lett. 2017;403:231-245.
    PubMed     Abstract available


  136. WESTDORP H, Kolders S, Hoogerbrugge N, de Vries IJM, et al
    Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Cancer Lett. 2017;403:159-164.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: